Biogen

Quarterly Financials

Values in thousands2025-12-312025-09-302025-06-302025-03-31
Revenue
$2,279,300
$2,454,800
$2,645,500
$2,431,000
Gross Profit
1,783,000
1,578,200
1,699,300
1,853,100
EBITDA
298,700
826,900
1,109,900
865,100
EBIT
-57,000
624,700
915,600
681,900
Net Income
-48,411
466,500
634,800
240,500
Net Change In Cash
2,279,300
2,454,800
2,645,500
2,431,000
Free Cash Flow
555,900
1,226,300
144,300
212,200
Cash
3,008,500
3,862,800
2,758,800
2,598,300
Basic Shares
146,700
147,100
145,900
145,900

Annual Financials

Values in thousands2025-12-312024-12-312023-12-312022-12-31
Revenue
$9,810,600
$9,675,900
$9,835,600
$10,173,400
Gross Profit
6,913,600
7,365,500
7,302,200
7,895,100
EBITDA
3,100,600
2,995,700
2,377,000
3,536,900
EBIT
2,165,200
2,322,500
1,882,200
3,018,500
Net Income
1,293,389
1,632,200
1,161,100
3,046,900
Net Change In Cash
9,810,600
9,675,900
9,835,600
10,173,400
Cost of Revenue
1,213,600
Free Cash Flow
2,050,800
2,515,700
1,235,800
1,144,000
Cash
3,008,500
2,375,000
1,049,900
3,419,300
Basic Shares
146,700
145,900
145,600
146,000

Earnings Calls

QuarterEPS
2026-03-31
$0
2025-12-31
$1.99
2025-09-30
$4.81
2025-06-30
$5.47